Join the Tinea Pedis group to help and get support from people like you.
Tinea Pedis News
Related terms: Athlete's Foot, Fungal Infection, Feet, Infection, Fungal, Feet, Ringworm, Foot, Tinea of the foot
FDA Medwatch Alert: Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
TARRYTOWN, N.Y.--(GLOBE NEWSWIRE)-February 1, 2024—Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 1% Tolnaftate Athlete’s ...
FDA Medwatch Alert: Odor-Eaters® Issues Voluntary Nationwide Recall of Specific Lots of Odor- Eaters® Spray Powder and Odor-Eaters® Stink Stoppers® Spray Due to Benzene Contamination
Odor-Eaters®, owned by Blistex Inc., is voluntarily recalling a total of forty-one lots of two Odor-Eaters® spray products to the consumer level due to the presence of benzene. Internal testing i...
FDA Medwatch Alert: Bayer Issues Voluntary Recall of Specific Lotrimin® and Tinactin® Spray Products Due to the Presence of Benzene
WHIPPANY, N.J., October 1, 2021 – Bayer is voluntarily recalling all unexpired Lotrimin® AF and Tinactin® spray products with lot numbers beginning with TN, CV or NAA, distributed between September 2...
FDA Approves Expanded Use of Luzu (luliconazole) Cream in Pediatric Patients with Athlete’s Foot, Jock Itch and Ringworm
RALEIGH, N.C., FEBRUARY 22, 2018 – Ortho Dermatologics, a division of Valeant Pharmaceuticals North America, LLC (NYSE: VRX and TSX: VRX) (“Valeant”), today announced that the U.S. Food and Drug Admin...
FDA Medwatch Alert: Nizoral (ketoconazole) Oral Tablets: Drug Safety Communication - Prescribing for Unapproved Uses including Skin and Nail Infections Continues; Linked to Patient Death
ISSUE: FDA is warning health care professionals to avoid prescribing the antifungal medicine ketoconazole oral tablets to treat skin and nail fungal infections. Use of this medication carries the...
Valeant Pharmaceuticals Announces U.S. Approval Of Luzu Cream, 1%
LAVAL, Quebec, Nov. 15, 2013 /PRNewswire/ – Valeant Pharmaceuticals International, Inc. announced today that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, has received...